Status:
WITHDRAWN
Evaluation and Follow-up of People With Tick-borne Diseases
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Lyme Disease
Tick-Borne Disease
Eligibility:
All Genders
18+ years
Brief Summary
Background: Lyme disease is the most common tick-borne disease in the United States, but other diseases transmitted by ticks have also been on the rise in recent years. Early symptoms of a tickborne ...
Detailed Description
Lyme disease is a multisystem illness caused by the spirochete Borrelia burgdorferi and it is the most common vector-borne illness in the United States. Tick-borne disease cases reported to the Center...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Clinical diagnosis of suspected, confirmed, or probable LB or other TBD per CDC case definitions.
- Has not received antibiotic therapy for tick-borne disease for more than 2 weeks.
- Age \>=18 years.
- Able to provide informed consent.
- Subjects must maintain a private physician for non-protocol related medical complaints and for emergency medical treatment required for these or other disorders.
- EXCLUSION CRITERIA:
- Post-treatment Lyme disease syndrome
- Women who report they are pregnant.
- Any other condition or history of unacceptably poor compliance that, in the opinion of the investigator, would make the patient unsuitable for enrollment or could interfere with the patient participating in and completing the study.
Exclusion
Key Trial Info
Start Date :
November 13 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 13 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04318925
Start Date
November 13 2023
End Date
November 13 2023
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland Baltimore, Department of Medicine
Baltimore, Maryland, United States, 21201